Saturday 17 October 2026
Export PLRZ’s income statement to Excel — free account
Polyrizon Ltd.
PLRZ Healthcare Biotechnology
10.00
0.01
−0.10%
Follow PLRZ
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
36.37 | 29.03 | 44.04 | 10.16 |
+3 more quarters Free account |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | — | |
Operating CF/Net income |
— | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
— | (0.02) | (0.01) | 0.00 | |
Intangible Assets out of Total Assets |
0.10 | 0.12 | 0.14 | 0.52 | |
Share Based Compensation of Revenue |
— | — | 0.00% | — | |
Free Cash Flow per Share |
— | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
— | (4.53) | (1.82) | (1.15) | |
Working Capital |
15.85 | 12.42 | 15.67 | 2.39 | |
Capital Expenditures |
— | (0.01) | 0.00 | 0.00 | |
Net Current Asset Value |
15.85 | 12.42 | 15.67 | 2.39 | |
| Other line items | |||||
Quick Ratio |
35.88 | 28.14 | 43.48 | 9.79 | |
Operating CF per Share |
— | 0.00 | 0.00 | 0.00 | |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | |
Average Assets |
12.72 | 11.00 | 9.64 | — | |
Average Common Equity |
12.19 | 10.40 | 8.74 | — | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 30 Sep 2026